RSS   Newsletter   Contact   Advertise with us
Post Online Media

AMAG Pharmaceuticals appoints VP, market access & corporate accounts

AMAG PharmaceuticalsAMAG Pharmaceuticals, a biopharmaceutical company, appoints Mark Stanton to the newly created position of vice president, market access and corporate accounts.

Mr. Stanton brings to AMAG more than 30 years of experience, most recently serving at AstraZeneca as the head of market access optimization since 2015 and the head of the U.S. diabetes market access function since 2013.

Article continues below

READ MORE VPG appoints Cary Wood to its board of directors

From 2007 to 2013, Mr. Stanton served as the vice president for market access and reimbursement for Medimmune, Inc., an AstraZeneca Biologics Division.

Prior to that, he served in a variety of corporate accounts and sales roles at a number of pharmaceutical companies.

Mr. Stanton holds a Bachelor of Science degree in business administration from Castleton State College, Vermont.

What to read next

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy